Global Acetazolamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acetazolamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.
Acetazolamide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acetazolamide market is projected to reach US$ 206.1 million in 2029, increasing from US$ 165.7 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2029. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Acetazolamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Acetazolamide key manufacturers include Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare and Strides Pharma, etc. Teva, TARO, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Acetazolamide can be divided into Tablets, Capsule and Injection,, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Acetazolamide is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Acetazolamide industry development. In 2022, global % sales of Acetazolamide went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acetazolamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Segment by Type
Tablets
Capsule
Injection
Hospital
Drug Store
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acetazolamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acetazolamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acetazolamide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Acetazolamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acetazolamide introduction, etc. Acetazolamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Acetazolamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Acetazolamide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acetazolamide market is projected to reach US$ 206.1 million in 2029, increasing from US$ 165.7 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2029. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Acetazolamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Acetazolamide key manufacturers include Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare and Strides Pharma, etc. Teva, TARO, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Acetazolamide can be divided into Tablets, Capsule and Injection,, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Acetazolamide is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Acetazolamide industry development. In 2022, global % sales of Acetazolamide went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acetazolamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Segment by Type
Tablets
Capsule
Injection
Segment by Application
Hospital
Drug Store
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acetazolamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acetazolamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acetazolamide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Acetazolamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acetazolamide introduction, etc. Acetazolamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Acetazolamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices